Literature DB >> 1268032

Carcinogenic effects of different nitroso-compounds in Chinese hamsters. I. Dimethylnitrosamine and N-diethylnitrosamine.

G Reznik, U Mohr, N Kmoch.   

Abstract

Three hundred and twenty Chinese hamsters (Cricetulus griseus) (CH) were treated (s.c.) with 1/5, 1/10 or 1/20 LD50 of dimethylnitrosamine (DMN) or N-diethylnitrosamine (DEN). These substances, in several respects, showed a different organotropy in this species than in both the Syrian golden (SGH) and the European hamster (EH). In CH, DEN produced up to 100% squamous cell papillomata and occasionally also carcinomata of the cheek pouch, tongue, pharynix, oesophagus and forestomach. With DEN a high rate of hepatomata was simultaneously realized. DMN induced a considerable quantity of liver tumours, the highest incidence being demonstrated in the lowest dosage group.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1268032      PMCID: PMC2025081          DOI: 10.1038/bjc.1976.66

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  13 in total

1.  [Carcinoma of the respiratory tract following treatment of the golden hamster with diethylnitrosamine].

Authors:  W DONTENWILL; U MOHR
Journal:  Z Krebsforsch       Date:  1961

2.  Carcinogenic effect of dibutylnitrosamine in European hamsters (Cricetus cricetus).

Authors:  J Althoff; U Mohr; N Page; G Reznik
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

3.  Diethylnitrosamine-induced alterations in the tracheobronchial system of Syrian golden hamsters.

Authors:  J Althoff; R Wilson; U Mohr
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

4.  Comparative studies of neoplastic response to a single dose of nitroso compounds. 3. The effect of N-nitrosopiperidine and N-nitrosomorpholine in Syrian golden hamsters.

Authors:  J Althoff; R Wilson; A Cardesa; P Pour
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1974

5.  Histogenesis of malignant liver tumors induced by dimethylnitrosamine. An experimental study in Syrian hamsters.

Authors:  K M Herrold
Journal:  J Natl Cancer Inst       Date:  1967-12       Impact factor: 13.506

6.  Comparative studies with different doses of N-nitrosomorpholine, N-nitrosopiperidine, N-nitrosomethylurea, and dimethylnitrosamine in Syrian golden hamsters.

Authors:  H Haas; U Mohr; F W Krüger
Journal:  J Natl Cancer Inst       Date:  1973-10       Impact factor: 13.506

7.  Dibutylnitrosamine carcinogenesis in Syrian Golden and Chinese hamsters.

Authors:  J Althoff; F W Krüger; U Mohr; D Schmahl
Journal:  Proc Soc Exp Biol Med       Date:  1971-01

8.  Experimental studies on the organotropic effect of nitrosamines in the respiratory tract.

Authors:  W Dontenwill
Journal:  Food Cosmet Toxicol       Date:  1968-12

9.  Carcinogenic effects of N-nitrosomorpholine and N-nitrosopiperidine on European hamster (Cricetus cricetus).

Authors:  U Mohr; G Reznik; H Reznik-Schüller
Journal:  J Natl Cancer Inst       Date:  1974-07       Impact factor: 13.506

10.  The carcinogenic effects of dimethylnitrosamine and nitrosomethylurea in European hamsters (Cricetus cricetus L.).

Authors:  U Mohr; H Haas; J Hilfrich
Journal:  Br J Cancer       Date:  1974-05       Impact factor: 7.640

View more
  3 in total

1.  Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers.

Authors:  Shahram Bahmanyar; Kazem Zendehdel; Olof Nyrén; Weimin Ye
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

2.  Carcinogenic effects of different nitroso-compounds in Chinese hamsters. II. N-nitrosomorpholine and N-nitrosopiperidine.

Authors:  G Reznik; U Mohr; N Kmoch
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-05-03

Review 3.  In Vivo Models for Cholangiocarcinoma-What Can We Learn for Human Disease?

Authors:  Raphael Mohr; Burcin Özdirik; Jana Knorr; Alexander Wree; Münevver Demir; Frank Tacke; Christoph Roderburg
Journal:  Int J Mol Sci       Date:  2020-07-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.